Novozymes As B Stock Market Value
| NVZMF Stock | USD 52.51 1.94 3.56% |
| Symbol | Novozymes |
Novozymes A/S 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novozymes A/S's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novozymes A/S.
| 01/24/2024 |
| 04/23/2024 |
If you would invest 0.00 in Novozymes A/S on January 24, 2024 and sell it all today you would earn a total of 0.00 from holding Novozymes AS B or generate 0.0% return on investment in Novozymes A/S over 90 days. Novozymes A/S is related to or competes with Air Liquide, Sherwin Williams, Ecolab, Air Products, Dupont De, and PPG Industries. Novozymes AS produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, N... More
Novozymes A/S Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novozymes A/S's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novozymes AS B upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.13 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 9.57 | |||
| Value At Risk | (3.28) | |||
| Potential Upside | 3.35 |
Novozymes A/S Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novozymes A/S's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novozymes A/S's standard deviation. In reality, there are many statistical measures that can use Novozymes A/S historical prices to predict the future Novozymes A/S's volatility.| Risk Adjusted Performance | 0.0298 | |||
| Jensen Alpha | 0.0358 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.1903 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novozymes A/S's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Novozymes AS B Backtested Returns
We consider Novozymes A/S very steady. Novozymes AS B has Sharpe Ratio of 0.0057, which conveys that the firm had a 0.0057% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Novozymes A/S, which you can use to evaluate the volatility of the firm. Please verify Novozymes A/S's Mean Deviation of 1.39, risk adjusted performance of 0.0298, and Downside Deviation of 2.13 to check out if the risk estimate we provide is consistent with the expected return of 0.0107%. The company secures a Beta (Market Risk) of 0.32, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Novozymes A/S's returns are expected to increase less than the market. However, during the bear market, the loss of holding Novozymes A/S is expected to be smaller as well. Novozymes AS B right now secures a risk of 1.86%. Please verify Novozymes AS B downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Novozymes AS B will be following its current price movements.
Auto-correlation | -0.84 |
Excellent reverse predictability
Novozymes AS B has excellent reverse predictability. Overlapping area represents the amount of predictability between Novozymes A/S time series from 24th of January 2024 to 9th of March 2024 and 9th of March 2024 to 23rd of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novozymes AS B price movement. The serial correlation of -0.84 indicates that around 84.0% of current Novozymes A/S price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.84 | |
| Spearman Rank Test | -0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 6.45 |
Novozymes AS B lagged returns against current returns
Autocorrelation, which is Novozymes A/S pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Novozymes A/S's pink sheet expected returns. We can calculate the autocorrelation of Novozymes A/S returns to help us make a trade decision. For example, suppose you find that Novozymes A/S has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Novozymes A/S regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Novozymes A/S pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Novozymes A/S pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Novozymes A/S pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Novozymes A/S Lagged Returns
When evaluating Novozymes A/S's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Novozymes A/S pink sheet have on its future price. Novozymes A/S autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Novozymes A/S autocorrelation shows the relationship between Novozymes A/S pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Novozymes AS B.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Novozymes A/S Correlation, Novozymes A/S Volatility and Novozymes A/S Alpha and Beta module to complement your research on Novozymes A/S. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Novozymes Pink Sheet analysis
When running Novozymes A/S's price analysis, check to measure Novozymes A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novozymes A/S is operating at the current time. Most of Novozymes A/S's value examination focuses on studying past and present price action to predict the probability of Novozymes A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novozymes A/S's price. Additionally, you may evaluate how the addition of Novozymes A/S to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Novozymes A/S technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.